HEALTH

Perpetual gets A$1.78B offer from NY firm

A New York-based private equity firm has offered to acquire Australia's Perpetual Ltd. (ASX: PPT) for A$1.75 billion to take advantage of the higher yielding assets available.

Stocks starts flat, commodities promising

Australia's S&P/ASX 200 is expected to ease from its early rally this week, as investors are wary of China's economic performance. Analysts said though there will be a positive push from the turn of events in the US with the Federal Reserve's decision to temper its fiscal policy, this will not easily avert the dampened mood that may set in today.

Australia to set a price on coal pollution

As the country struggles to retain its global competitiveness but retaining its current energy production levels to sustain local industries, the Australian Parliament has chosen to put a price on coal emissions.
More news

Bonsoy faces multi-million-dollar class suit

Spiral Foods Proprietary Limited is pulled to the court room for distributing soy milk products that allegedly caused people to suffer from thyroid problems.

Long wait for Sigma shareholders

The new director of Sigma Pharmaceutical Limited (ASX: SIP) warned of a 12 month recovery period for the company.

All natural label ripped off from ice cream

The Center for Science in the Public Interest (CSPI) and ice cream company Ben and Jerry settled for dropping the phrase 'all natural' from all product labels.

WA hospital union demands pay hike

The Liquor Hospitality and Miscellaneous Workers Union (LHMU) insists on a reasonable pay increase in order to end the work-to-rule ban in hospitals across Western Australia.

FIRB gives the go-ahead to Healthscope takeover

The Foreign Investment Review Board (FIRB) has given private equity firms The Carlyle Group and TPG Capital the green light to takeover health provider Healthscope Ltd (ASX:HSP).

Flu drug approval sends Biota shares up 20%

Melbourne drug developer Biota Holdings (ASX:BTA) has soared more than 20 per cent on reports its Japanese partner has been given the go-ahead to sell an influenza drug.

ACT Health warns food business

The Australian Central Territory (ACT) Health is using an ACT Supreme Court decision as a warning to the food and beverage industry.

Broadvector focuses on prostate cancer, hip replacements

The biotechnology company is floating $8.5 million today after submitting a prospectus with the Australian Securities and Investments Commission. The investment proposal covers the clinical development of a new prostate cancer therapy and a second therapy to improve the longevity of hip replacements.

Sigma faces potential class-action lawsuit

Sigma Pharmaceuticals Ltd (ASX:SIP) says it has been advised of a shareholder class action lawsuit over its alleged failure to disclose its financial position before a capital raising in September 2009.

811 McDonald's stores in Australia

In the past three years, McDonald's in Australia has opened 50 new stores to meet the rising demand for its fast food products. The new stores brings the total number of McDonald's outlets in Australia to 811.

Australian organic industry to hit $1bn retail in 2010

The Australian organic industry is tipped this year to become an AUS$1 Billion industry, according to independent research report commissioned by the Biological Farmers of Australia (BFA).

Pizza Hut Goes For Less Salt

Pizza lovers in Australia will soon have a healthy alternative with Pizza Hut's latest less salt line of pizza products. Customers will enjoy 45 percent less sodium starting next year.

Healthscope posts 37% profit rise in FY10

Australian healthcare service provider Healthscope Ltd (ASX:HSP) has announced a 37 per cent rise in annual profit and projects solid demand and growth in the year ahead.

Primary Health Care net profit up 22% to $132m

Australia-based medical centre operator and pathology provider Primary Health Care (ASX:PRY) has announced a 21.7 per cent increase in net profit but expects earnings in the current year to be at the lower end of earlier guidance.

Sigma sells drugs arm for $900m

Sigma Pharmaceuticals Ltd (ASX:SIP) has agreed to hand its pharmaceuticals division to South Africa's Aspen Pharmacare Holdings Ltd for $900 million.

Sigma denies receiving higher offer from Aspen

Sigma Pharmaceuticals (ASX:SIP) has denied market rumours it has received a higher 65¢-a-share takeover bid from South Africa's Aspen Pharmacare Holdings.

Cochlear's annual profit up 19%

Cochlear (ASX:COH), maker of the world's best-selling hearing implant, has recorded a 19 per cent increase in annual net profit.

Watson possibly eyeing Sigma

US-based Watson Pharmaceuticals (NYSE:WPI) has not ruled out a $600 million takeover bid for Australian healthcare group Sigma Pharmaceuticals (ASX:SIP).

Health organisation urge political parties to support plain packaging of tobacco

Cancer Council Australia and the National Heart Foundation of Australia today called on all political parties to back the plan to phase in plain packaging of tobacco products, as a new, big-budget media campaign funded by the tobacco industry seeks to roll back the important health measure.

GPs resent health minister’s remarks

Family doctors will resent comments made by the Federal Health Minister Nicola Roxon that GPs who have medical practices near government-funded Super Clinics need to question the services they offer, said Dr Adrian Sheen, President of Doctors Action.

ABS data say most Australians use health services

The Australian Bureau of Statistics released today the results of the first national Patient Experience Survey examining health care for Australians in the last 12 months.

CSL expands major biotech facility

CSL boosts the medical research capacities of Victoria with its announcement of the expansion of primary biotech facility worth $235 million.

Sigma cuts annual profit forecast

Sigma Pharmaceuticals Ltd has downgraded its profit forecast for the full year by around 31 percent as it strives to convince Aspen Pharmacare to up its takeover bid worth $A649.73 million ($US573 million).

Stock market starts sluggish

A sluggish morning trading affected Australia's stock market S&P/ASX 200 Index as it declined 0.3 percent to 4,397.50 as of 12:48 p.m. in Sydney. New Zealand's NZX 50 Index shed off 0.3 percent to 3,004.56 in Wellington.

Sigma Pharma wants better deal with Aspen

Australian pharmaceutical firm, Sigma Pharmaceuticals Ltd., that has lost more than half its market value this year, said it is willing to work a better deal with Aspen Pharmacare Holdings Ltd. to have a better offer.

Pages

  • Prev
  • 5
  • 6
  • 7
  • 8
  • 9